Alnylam Pharmaceuticals, Inc. planned insider sales
In the last twelve months insiders at Alnylam Pharmaceuticals, Inc. filed 12 Form 144 notices of planned sales, 61,099 shares worth $24.5 million at the time of filing, from 6 sellers. The latest, filed 2 October 2026: Supran Bryan (officer), 1,758 shares worth $398,862, planned for around 2 October 2026 through Fidelity Brokerage Services LLC.
| Filed | Seller | Relationship | Shares | Value | Planned sale | Sold, per Form 4 | Broker | How acquired | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 2 October 2026 | Supran Bryan | Officer | 1,758 | $398,862 | 2 October 2026 | 1,758 shares from 2 October 2026 | Fidelity Brokerage Services LLC | Restricted Stock Vesting | Form 144 |
| 1 June 2026 | Pyott David E I | Director | 3,830 | $1.1 million | 1 June 2026 | 3,830 shares from 1 June 2026 | UBS Financial Services, Inc. | Exercise of stock options | Form 144 |
| 6 April 2026 | McLaughlin Melissa | Officer | 2,286 | $731,749 | 6 April 2026 | 2,286 shares from 6 April 2026 | UBS Financial Services, Inc. | Stock Award | Form 144 |
| 5 March 2026 | Fitzgerald Kevin Joseph | Officer | 658 | $212,988 | 5 March 2026 | 1,291 shares from 4 March 2026 | UBS Financial Services, Inc. | RSU | Form 144 |
| 5 March 2026 | Garg Pushkal | Officer | 2,404 | $778,151 | 5 March 2026 | 4,713 shares from 4 March 2026 | UBS Financial Services, Inc. | RSU | Form 144 |
| 3 March 2026 | Fitzgerald Kevin Joseph | Officer | 1,652 | $530,903 | 3 March 2026 | 3,250 shares from 2 March 2026 | UBS Financial Services, Inc. | RSU | Form 144 |
| 3 March 2026 | Garg Pushkal | Officer | 1,775 | $570,432 | 3 March 2026 | 3,492 shares from 2 March 2026 | UBS Financial Services, Inc. | RSU | Form 144 |
| 27 February 2026 | Garg Pushkal | Officer | 4,627 | $1.5 million | 27 February 2026 | 4,627 shares from 27 February 2026 | UBS Financial Services, Inc. | PSU | Form 144 |
| 17 February 2026 | Fitzgerald Kevin Joseph | Officer | 2,041 | $677,532 | 17 February 2026 | 2,041 shares from 17 February 2026 | UBS Financial Services, Inc. | PSU | Form 144 |
| 13 January 2026 | Fitzgerald Kevin Joseph | Officer | 2,290 | $845,239 | 13 January 2026 | 5,759 shares from 12 January 2026 | UBS Financial Services, Inc. | PSU | Form 144 |
| 17 November 2025 | Fitzgerald Kevin Joseph | Officer | 12,128 | $5.4 million | 17 November 2025 | 12,128 shares from 17 November 2025 | UBS Financial Services, Inc. | Exercise of stock options; PSU | Form 144 |
| 12 November 2025 | Greenstreet Yvonne | Officer, Director | 25,650 | $11.6 million | 12 November 2025 | 35,227 shares from 12 November 2025 | UBS Financial Services, Inc. | Exercise of stock options | Form 144 |
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.